Dermasporin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Dermasporin
Generic name: LANOLIN
Manufacturer: Marie's Original Formulas LLC
Product type: HUMAN OTC DRUG
SPL set ID: 562f40aa-eeec-2b7c-e063-6294a90ad68d
SPL ID: 5738b40a-8261-9a9e-e063-6394a90a1f15
Version: 2
Effective date: 2026-07-22
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:26:40

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M016	openfda.application_number
brand name		Dermasporin	openfda.brand_name
generic name		LANOLIN	openfda.generic_name
manufacturer name		Marie's Original Formulas LLC	openfda.manufacturer_name
ndc	package	87541-507-04	openfda.package_ndc
ndc	product	87541-507	openfda.product_ndc
ndc11	package	87541050704	derived:openfda.package_ndc
spl id		5738b40a-8261-9a9e-e063-6394a90a1f15	id
spl set id		562f40aa-eeec-2b7c-e063-6294a90ad68d	set_id
unii		7EV65EAW6H	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use • On deep or puncture wounds. • On animal bites. • On serious burns. When using this product • Do not get into eyes. Stop use and ask a doctor if • Condition worsens. • Symptoms last more than 7 days or clear up and occur again within a few days.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.